Literature DB >> 1486112

Alopecia and mood stabilizers: two case reports.

C Uehlinger1, L Barrelet, M Touabi, P Baumann.   

Abstract

Two cases of alopecia observed during treatment with lithium and valproate are described, and the recent literature on this subject is reviewed. Our clinical observations confirm earlier reports. These toxic alopecias are characterized by a diffuse but rarely total hair loss. After stopping medication, the hair grows back generally and completely. Two cases of toxic alopecia are presented where hair grew back following a substitution of lithium by valproate in the first case and after stopping valproate in the second. The evaluation and therapeutic attitude in the presence of alopecia in patients needing mood stabilizers are also discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486112     DOI: 10.1007/bf02191552

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  32 in total

1.  Severe hair loss associated with fluoxetine use.

Authors:  M A Jenike
Journal:  Am J Psychiatry       Date:  1991-03       Impact factor: 18.112

2.  Side effects and teratogenicity of lithium carbonate treatment.

Authors:  L Vacaflor; H E Lehmann; T A Ban
Journal:  J Clin Pharmacol J New Drugs       Date:  1970 Nov-Dec

3.  Alopecia areata during lithium therapy. A case report.

Authors:  A Silvestri; P Santonastaso; D Paggiarin
Journal:  Gen Hosp Psychiatry       Date:  1988-01       Impact factor: 3.238

4.  Change in hair colour induced by valproic acid.

Authors:  J L Herranz; R Arteaga; J A Armijo
Journal:  Dev Med Child Neurol       Date:  1981-06       Impact factor: 5.449

5.  Hair loss following lithium therapy.

Authors:  A Orwin
Journal:  Br J Dermatol       Date:  1983-04       Impact factor: 9.302

6.  Carbamazepine as an adjunct of antipsychotic therapy.

Authors:  M Dose; S Apelt; H M Emrich
Journal:  Psychiatry Res       Date:  1987-12       Impact factor: 3.222

7.  Sodium valproate in the treatment of resistant epilepsy.

Authors:  M N Hassan; H C Laljee; M J Parsonage
Journal:  Acta Neurol Scand       Date:  1976-09       Impact factor: 3.209

Review 8.  Drug-related alopecia.

Authors:  M B Brodin
Journal:  Dermatol Clin       Date:  1987-07       Impact factor: 3.478

9.  Sodium valproate: monotherapy and polytherapy.

Authors:  A Covanis; A K Gupta; P M Jeavons
Journal:  Epilepsia       Date:  1982-12       Impact factor: 5.864

10.  Report of a patient with lithium-related alopecia and psoriasis.

Authors:  A M Ghadirian; M Lalinec-Michaud
Journal:  J Clin Psychiatry       Date:  1986-04       Impact factor: 4.384

View more
  1 in total

1.  Serum drug level-related sodium valproate-induced hair loss.

Authors:  Suresh K Ramakrishnappa; Mahesh N Belhekar
Journal:  Indian J Pharmacol       Date:  2013 Mar-Apr       Impact factor: 1.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.